CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 32 enrolled
Drug / intervention
Dexmedetomidine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02515890
NCT02515890Phase 1Completed

Modulation of Long-term Memory by the Experience of Pain During Sedation With Anesthetics

University of Pittsburgh·interventional·Posted Aug 5, 2015·Updated Jul 1, 2020

In Brief

A Phase 1 clinical trial evaluating Dexmedetomidine, Midazolam, and 2 other interventions for Amnesia and 2 related conditions. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the effects of pain on facilitating long-term auditory memory in the presence and absence of distinct intravenous anesthetics. The ability to identify previously presented words from a list assessed the degree of memory formation. In a subset of subjects, functional magnetic resonance imaging was used to identify the neural correlates of memory inhibition or facilitation by the combination of pain and anesthetic used.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmnesia, Pain, Anesthesia
CountriesUnited States

Timeline

Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 5, 2015
Enrollment StartNov 19, 2015
Primary CompletionDec 12, 2018
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 10.9 years ago

Interventions

Dexmedetomidinedrug

Selected subjects received this drug during a portion of the study

Midazolamdrug

Selected subjects received this drug during a portion of the study

Peripheral nerve stimulationdevice

Experimental acute pain stimulus was delivered using a nerve stimulator. These painful shocks were paired randomly with some of the auditory experimental cues.

Ketaminedrug

Selected subjects received this drug during a portion of the study